Trial Profile
A phase II observational study of IB-1000 for Late-Onset Tay Sachs (LOTS) disease
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Nov 2018
Price :
$35
*
At a glance
- Drugs Acetylleucine (Primary)
- Indications Tay-Sachs disease
- Focus Therapeutic Use
- 26 Nov 2018 New trial record